{"source": ["Pfizer\u2019s vaccine debuts in Britain as the world\u2019s first fully tested vaccine.. Britain\u2019s National Health Service delivered its first shots of the Pfizer-BioNTech Covid-19 vaccine on Tuesday, opening a mass vaccination campaign with little precedent in modern medicine and making Britons the first people in the world to receive a clinically authorized, fully tested vaccine.", "In COVID-19 milestone for West, Britain starts mass vaccination. A 90-year-old grandmother became the world\u2019s first person to receive a fully-tested COVID-19 shot on Tuesday, as Britain began mass-vaccinating its people in a global drive that poses one of the biggest logistical challenges in peacetime history. Health workers started inoculating the most vulnerable with the vaccine developed by Pfizer and BioNTech, with the country a test case for the world as it contends with distributing a compound that must be stored at -70C (-94F).", "90-year-old woman is first to receive Pfizer Covid-19 vaccine in UK. Margaret Keenan, 90, reportedly said she felt \u201cprivileged\u201d when she became the first person in the United Kingdom to receive the Pfizer/BioNTech coronavirus vaccine early Tuesday in Coventry, England. The BBC reported that the vaccine was administered at 6:30 a.m. GMT. Around 800,000 doses of the vaccine were expected to be in place for the start of the immunization program on Tuesday, a day that Health Secretary Matt Hancock has reportedly dubbed as \u201cV-Day,\u201d a nod to triumphs in World War II."], "target": "UK Begins Distribution of Pfizer COVID-19 Vaccine. The United Kingdom has begun distributing the world\u2019s first fully tested, clinically authorized COVID-19 coronavirus vaccine. The first recipient was a 90-year-old woman named Margaret Keenan, followed by an 81-year-old man named William Shakespeare. The vaccine, developed by American pharmaceutical company Pfizer and German biotechnology company BioNTech, was approved by British authorities in early December. The U.K. has so far received enough doses for 400,000 people, and will prioritize distribution to health workers and people older than 80. The FDA is expected to make a decision on U.S. vaccine authorization later this week. "}